JAMA Dermatology

<jats:sec id="ab-doi230063-4"><jats:title>Importance</jats:title><jats:p>While acne is common in transgender and gender-diverse people and is associated with gender-affirming hormone therapy, little research has examined these factors and their impact in gender minority groups.</jats:p></jats:sec><jats:sec id="ab-doi230063-5"><jats:title>Objective</jats:title><jats:p>To examine the lived experiences of acne and acne treatment in transgender and gender-diverse participants.</jats:p></jats:sec><jats:sec id="ab-doi230063-6"><jats:title>Design, Setting, and Participants</jats:title><jats:p>This mixed-methods analysis was conducted at a multidisciplinary gender center at a public safety-net hospital and endocrinology and dermatology clinics at a tertiary academic center from January 4, 2021, to April 7, 2022, using semistructured interviews and surveys. Participants were transgender or gender-diverse adults who had received gender-affirming hormone therapy. Data analysis was performed from November 11, 2021, to March 31, 2023.</jats:p></jats:sec><jats:sec id="ab-doi230063-7"><jats:title>Exposure</jats:title><jats:p>Current diagnosis of acne.</jats:p></jats:sec><jats:sec id="ab-doi230063-8"><jats:title>Main Outcomes and Measures</jats:title><jats:p>Interviews exploring the experience of acne and acne treatment were audio recorded, transcribed verbatim, coded using minority stress theory and the socioecological model, and analyzed using thematic analysis. Themes were triangulated with survey data on gender, self-reported acne severity, skin-specific quality-of-life impact, and treatment experience.</jats:p></jats:sec><jats:sec id="ab-doi230063-9"><jats:title>Results</jats:title><jats:p>A total of 32 participants were included in the study (mean [range] age, 32 [18-57] years; 17 transgender men, 11 transgender women, and 4 nonbinary participants). Ten participants (31%) self-rated their skin as currently clear or almost clear, 11 (34%) reported mild acne, and 11 (34%) had moderate to severe acne. Participants described experiences of rejection and bullying related to acne and admitted avoiding social interactions in which they anticipated acne-related discrimination, which led to feelings of depression and anxiety. Acne worsened body appearance dissatisfaction. Transgender women reported acne interfering with feminine gender expression. Transgender men often normalized acne development, sometimes viewing acne positively as an early sign of testosterone action. Most participants tried over-the-counter acne treatments and commonly sought acne treatment advice from physicians, peers, online forums, and social media. Barriers to acne treatments included cost, lack of multidisciplinary care, mistrust toward the health care system, and lack of transgender-specific acne care education.</jats:p></jats:sec><jats:sec id="ab-doi230063-10"><jats:title>Conclusions and Relevance</jats:title><jats:p>In this mixed-methods study, transgender and gender-diverse individuals reported experiencing acne-related stigma and facing barriers to acne treatment. Multilevel changes, such as developing strategies to reduce acne stigma, providing transgender-specific acne care education, facilitating multidisciplinary acne care, and expanding transgender-friendly clinical environments, are recommended to reduce the impact of acne in transgender individuals.</jats:p></jats:sec>

Acne vulgaris and risk of depression and anxiety: a meta-analytic review.

J Am Acad Dermatol

Patient perspectives on the lived experience of acne and its treatment among adult women with acne: a qualitative study.

JAMA Dermatol

Young people’s perceptions of acne and acne treatments: secondary analysis of qualitative interview data.

Br J Dermatol

Short- and long-term clinical skin effects of testosterone treatment in trans men.

J Sex Med

Incidence and factors associated with acne among transgender patients receiving masculinizing hormone therapy.

Perceptions of barriers to and facilitators of participation in health research among transgender people.

Transgend Health

Standards of care for the health of transgender and gender diverse people.

Int J Transgender Health

Achieving consensus on patient-reported outcome measures in clinical practice for inflammatory skin disorders.

Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases.

J Cutan Med Surg

Development of a comprehensive quality-of-life measure for facial and torso acne.

Patient-reported outcome measures for health-related quality of life in patients with acne vulgaris: a systematic review of measure development and measurement properties.

A conceptual framework for clinical work with transgender and gender nonconforming clients: an adaptation of the Minority Stress Model.

Prof Psychol Res Pr

Expecting rejection: understanding the minority stress experiences of transgender and gender-nonconforming individuals.

Severe acne in female-to-male transgender patients.

Prescribing isotretinoin in the United States for transgender individuals: ethical considerations.

Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups.

Int J Qual Health Care

The use of triangulation in qualitative research.

Oncol Nurs Forum

Psychological sequelae of acne vulgaris: results of a qualitative study.

Can Fam Physician

A Qualitative investigation of the impact of acne on health-related quality of life (HRQL): development of a conceptual model.

Dermatol Ther (Heidelb)

‘Nobody likes damaged goods’: the experience of adult visible acne.

Br J Health Psychol

The transgender identity survey: a measure of internalized transphobia.

LGBT Health

Truncal acne in adolescents and young adults: self-reported perception.

Acta Derm Venereol

Beyond the face: the hidden burden of truncal acne.

Incidence and factors associated with acne in transgender adolescents on testosterone: a retrospective cohort study.

Endocr Pract

Effect of cross-sex hormones on the quality of life, depression and anxiety of transgender individuals: a quantitative systematic review.

JBI Database System Rev Implement Rep

Moderate-to-severe acne and mental health symptoms in transmasculine persons who have received testosterone.

Treating acne in transgender persons receiving testosterone: a practical guide.

Am J Clin Dermatol

Dermatologic care for lesbian, gay, bisexual, and transgender persons: terminology, demographics, health disparities, and approaches to care.

Removal of isotretinoin gender-based guidelines: inclusivity takes precedence.

Cutis

Contraception across the transmasculine spectrum.

Am J Obstet Gynecol

Society of family planning clinical recommendations: contraceptive counseling for transgender and gender diverse people who were female sex assigned at birth.

Contraception

Psychiatric adverse events in patients taking isotretinoin as reported in a Food and Drug Administration database from 1997 to 2017.

Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study.

Retinoic acid and affective disorders: the evidence for an association.

J Clin Psychiatry

Use of isotretinoin and risk of depression in patients with acne: a systematic review and meta-analysis.

BMJ Open

Anxiety and depression in transgender individuals: the roles of transition status, loss, social support, and coping.

J Consult Clin Psychol

Baseline physiologic and psychosocial characteristics of transgender youth seeking care for gender dysphoria.

J Adolesc Health

While acne is common in transgender and gender-diverse people and is associated with gender-affirming hormone therapy, little research has examined these factors and their impact in gender minority groups.
To examine the lived experiences of acne and acne treatment in transgender and gender-diverse participants.
This mixed-methods analysis was conducted at a multidisciplinary gender center at a public safety-net hospital and endocrinology and dermatology clinics at a tertiary academic center from January 4, 2021, to April 7, 2022, using semistructured interviews and surveys. Participants were transgender or gender-diverse adults who had received gender-affirming hormone therapy. Data analysis was performed from November 11, 2021, to March 31, 2023.
Current diagnosis of acne.
Interviews exploring the experience of acne and acne treatment were audio recorded, transcribed verbatim, coded using minority stress theory and the socioecological model, and analyzed using thematic analysis. Themes were triangulated with survey data on gender, self-reported acne severity, skin-specific quality-of-life impact, and treatment experience.
A total of 32 participants were included in the study (mean [range] age, 32 [18-57] years; 17 transgender men, 11 transgender women, and 4 nonbinary participants). Ten participants (31%) self-rated their skin as currently clear or almost clear, 11 (34%) reported mild acne, and 11 (34%) had moderate to severe acne. Participants described experiences of rejection and bullying related to acne and admitted avoiding social interactions in which they anticipated acne-related discrimination, which led to feelings of depression and anxiety. Acne worsened body appearance dissatisfaction. Transgender women reported acne interfering with feminine gender expression. Transgender men often normalized acne development, sometimes viewing acne positively as an early sign of testosterone action. Most participants tried over-the-counter acne treatments and commonly sought acne treatment advice from physicians, peers, online forums, and social media. Barriers to acne treatments included cost, lack of multidisciplinary care, mistrust toward the health care system, and lack of transgender-specific acne care education.
In this mixed-methods study, transgender and gender-diverse individuals reported experiencing acne-related stigma and facing barriers to acne treatment. Multilevel changes, such as developing strategies to reduce acne stigma, providing transgender-specific acne care education, facilitating multidisciplinary acne care, and expanding transgender-friendly clinical environments, are recommended to reduce the impact of acne in transgender individuals.

Lived Experience of Acne and Acne Treatment in Transgender Patients.

Lived Experience of Acne and Acne Treatment in Transgender Patients

Lived Experience of Acne and Acne Treatment in Transgender Patients

Clinical Summary

What was studied

Key findings

Study limitations

Clinical implications

Related Questions